134 related articles for article (PubMed ID: 33984617)
1. Incorporation of simvastatin into lipid membranes: Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin.
Bartkowiak A; Matyszewska D; Krzak A; Zaborowska M; Broniatowski M; Bilewicz R
Colloids Surf B Biointerfaces; 2021 Aug; 204():111784. PubMed ID: 33984617
[TBL] [Abstract][Full Text] [Related]
2. Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-cyclodextrin complex.
Dos Santos AG; Bayiha JC; Dufour G; Cataldo D; Evrard B; Silva LC; Deleu M; Mingeot-Leclercq MP
Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1930-1940. PubMed ID: 28642042
[TBL] [Abstract][Full Text] [Related]
3. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
Bartkowiak A; Nazaruk E; Gajda E; Godlewska M; Gaweł D; Jabłonowska E; Bilewicz R
ACS Biomater Sci Eng; 2022 Oct; 8(10):4354-4364. PubMed ID: 36173110
[TBL] [Abstract][Full Text] [Related]
6. Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.
Aytac Z; Sen HS; Durgun E; Uyar T
Colloids Surf B Biointerfaces; 2015 Apr; 128():331-338. PubMed ID: 25769282
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antibacterial activity of levofloxacin/hydroxypropyl-β-cyclodextrin inclusion complex: In vitro and in vivo evaluation.
Li Y; Zhou J; Gu J; Shao Q; Chen Y
Colloids Surf B Biointerfaces; 2022 Jul; 215():112514. PubMed ID: 35490541
[TBL] [Abstract][Full Text] [Related]
8. Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins.
Arsiccio A; Rospiccio M; Shea JE; Pisano R
J Phys Chem B; 2021 Jul; 125(27):7397-7405. PubMed ID: 34210121
[TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins.
Al-Husseini JK; Fong EM; Wang C; Ha JH; Upreti M; Chiarelli PA; Johal MS
Langmuir; 2023 Sep; 39(36):12590-12598. PubMed ID: 37651551
[TBL] [Abstract][Full Text] [Related]
10. Statin Action Targets Lipid Rafts of Cell Membranes: GIXD/PM-IRRAS Investigation of Langmuir Monolayers.
Zaborowska M; Broniatowski M; Fontaine P; Bilewicz R; Matyszewska D
J Phys Chem B; 2023 Aug; 127(32):7135-7147. PubMed ID: 37551973
[TBL] [Abstract][Full Text] [Related]
11. pH dependence of daunorubicin interactions with model DMPC:Cholesterol membranes.
Matyszewska D; Brzezińska K; Juhaniewicz J; Bilewicz R
Colloids Surf B Biointerfaces; 2015 Oct; 134():295-303. PubMed ID: 26209780
[TBL] [Abstract][Full Text] [Related]
12. X-ray grazing incidence diffraction and Langmuir monolayer studies of the interaction of beta-cyclodextrin with model lipid membranes.
Flasiński M; Broniatowski M; Majewski J; Dynarowicz-Łatka P
J Colloid Interface Sci; 2010 Aug; 348(2):511-21. PubMed ID: 20493495
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin-induced lipid lateral separation in DMPC membranes: (2)H nuclear magnetic resonance study.
Roux M; Auzely-Velty R; Djedaini-Pilard F; Perly B
Biophys J; 2002 Feb; 82(2):813-22. PubMed ID: 11806923
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
Gu F; Ning J; Fan H; Wu C; Wang Y
Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
[TBL] [Abstract][Full Text] [Related]
16. Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin.
Koushik KN; Bandi N; Kompella UB
Pharm Dev Technol; 2001 Nov; 6(4):595-606. PubMed ID: 11775960
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.
Zhang H; Chen M; He Z; Wang Z; Zhang M; He Z; Wan Q; Liang D; Repka MA; Wu C
AAPS PharmSciTech; 2013 Mar; 14(1):10-8. PubMed ID: 23160918
[TBL] [Abstract][Full Text] [Related]
18. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
Joguparthi V; Anderson BD
Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
